Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
HSCS

HSCS - Heart Test Laboratories, Inc. Stock Price, Fair Value and News

$3.27-0.07 (-2.10%)
Market Closed

6/100

HSCS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

6/100

HSCS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.76

Target 3M

$3.11

Target 6M

$2.93

HSCS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HSCS Price Action

Last 7 days

-10.7%

Last 30 days

3.2%

Last 90 days

10.5%

Trailing 12 Months

-0.6%

HSCS RSI Chart

HSCS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HSCS Valuation

Market Cap

10.4M

Price/Earnings (Trailing)

-1.15

Price/Sales (Trailing)

1.8K

Price/Free Cashflow

-1.03

HSCS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.76

Target 3M

$3.11

Target 6M

$2.93

HSCS Fundamentals

HSCS Revenue

Revenue (TTM)

4.3K

HSCS Earnings

Earnings (TTM)

-9.0M

Earnings Growth (Yr)

-12.86%

Earnings Growth (Qtr)

-14.39%

HSCS Profitability

Operating Margin

56.78%

Return on Equity

-216.05%

Return on Assets

-150.7%

Free Cashflow Yield

-96.73%

HSCS Investor Care

Shares Dilution (1Y)

224.20%

Diluted EPS (TTM)

-6.87

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202504.3K00
202420.6K18.6K00
20239.3K5.2K05.8K
202217.2K14.4K10.1K10.1K
2021025.6K22.8K20.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Heart Test Laboratories, Inc.

HSCS
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
 CEO
 WEBSITEhttps://heartsciences.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES12

Heart Test Laboratories, Inc. Frequently Asked Questions

HSCS is the stock ticker symbol of Heart Test Laboratories, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Heart Test Laboratories, Inc. is 10.39 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check HSCS's fair value in chart for subscribers.

The fair value guage provides a quick view whether HSCS is over valued or under valued. Whether Heart Test Laboratories, Inc. is cheap or expensive depends on the assumptions which impact Heart Test Laboratories, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HSCS.

As of Wed Jan 28 2026, HSCS's PE ratio (Price to Earnings) is -1.15 and Price to Sales (PS) ratio is 1.78 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HSCS PE ratio will change depending on the future growth rate expectations of investors.